MALAT1 and Parkinson disease: Yang [27] et al. found that PD patients with high serum MALAT1 levels had lower Simple Mental State Evaluation Scale (MMSE) scores and higher serum levels of IL-1β, IL-6, TNF-α and IFN-γ.